Navigation Links
Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies
Date:9/7/2010

NEW YORK, Sept. 7  /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies

http://www.reportlinker.com/p0289100/The-Top-10-Orthopedic-Device-Companies-Financial-performance-research-activities-and-growth-strategies.html

The orthopedic device industry is highly competitive and has reached maturity, as demonstrated by its single digit growth rate. The industry is driven largely by incremental innovation and breakthrough product launches have stalled. Several product lines are also facing severe commoditization due to increased competition. Despite such high levels of competition, the top 15 companies accounted for 95% of the market in 2009. The largest device segments are spinal, knee, and hip implants. The fastest growing segment is orthobiologics.

The report provides detailed profiles of the top 10 orthopedic device companies and brief profiles of five other major players. It elucidates trends associated with companies that develop, manufacture, and market orthopedic devices. Detailed profiles contain descriptions of products, financial performance, and growth strategies together with SWOT analyses. For each company analysis is based on:

  • Each company's consolidated and segmental financial performance;
  • Each company's growth strategies and major acquisitions and divestments relating to the CV devices market;
  • Key partnerships and alliances formed by these companies;
  • Business-related strengths and weaknesses of these companies, and insights into the opportunities and threats facing them.

  • Key drivers and resistors to growth of leading CV device companies.

    Drivers

  • Demographics – aging population
  • Preference for biologic implants increasing
  • Growth in emerging markets
  • Physician preferences boosted by CME programs
  • Continued innovation

  • Resistors

  • Increasing pricing pressure from buyers and payers
  • Rising usage of comparative efficacy and health economics data
  • Regulatory demand for postmarketing surveillance
  • Review of the PMN pathway in the US
  • Medical device excise tax amounting to $20bn over the next 20 years

  • Key benefits of reading this report

  • Learn from the business operation strategies of the premier orthopedic device companies to target future growth markets effectively, avoid their mistakes, and replicate their successes.
  • Benchmark your performance against the leading orthopedic device companies.
  • Analyze the growth strategies of major players in the orthopedic industry and learn how their business models are planned for the next 3 to 5 years .
  • Compare performances of the top 10 companies in the orthopedic market with respect to acquisitions, new product innovation, geography expansion, and industry challenges.
  • Save time, money, and resources on analyzing the performance of leading orthopedic device companies using this report.

  • Key findings from this report

  • The global orthopedic market had an estimated $33bn size in 2009, a Y-o-Y increase of 7.1%. The market is moderately dependent on macroeconomic trends and demographics.
  • In 2009, the market growth was adversely affected by patient deferral of orthopedic procedures and increased pricing pressure from buyers. Market performance was also considerably impacted by currency fluctuations, owing to a strengthening US dollar. This is due to the fact that majority of orthopedic companies are based in the US.
  • Spine, knee, and hip implants formed the largest orthopedic market segments in 2009, and accounted for nearly $18.2bn sales. Surgical accessories used in orthopedic procedures represent the most fragmented market segment, followed by spinal devices. The orthobiologics segment has the least competition and was also fastest growing segment.
  • Regulatory pressure on the orthopedic market will significantly rise due to the impending review of the PMN pathway, the Physician Payment Sunshine Act and application of comparative effectiveness research (CER) information by buyers and payers.
  • Along with CER studies, the impending $20bn medical device tax will add further pricing pressures.

  • Key questions answered by this report

  • What was the market value of the global orthopedic device industry in 2009?
  • What are the global market values for the major orthopedic device segments?
  • What are the key trends observed in the orthopedic device companies and what are the strategic responses that are taking shape?
  • Who are the major players in the global orthopedic device market?
  • What are the growth strategies of the leading orthopedic device companies?
  • What are the strengths, weaknesses, opportunities and threats faced by the top 10 players?

  • Table of ContentsAbout Business Insights 2

    Disclaimer 2

    Executive summary 11

    Industry overview 11

    Stryker 11

    DePuy 12

    Zimmer 12

    Medtronic 13

    Synthes 13

    Smith & Nephew 14

    Biomet 14

    Orthofix 14

    Wright Medical Group 15

    Conmed 15

    Chapter 1 Introduction 17

    What is this report about? 17

    Methodology 17

    Chapter 2 Industry overview 18

    Summary 18

    Introduction 18

    Market segmentation 20

    Competitive landscape 21

    Key drivers and resistors 22

    Key events and trends 23

    Changes in the PMN pathway will increase regulatory burden 23

    CME platforms will continue to drive growth despite the Department of Justice (DOJ) clampdown 24

    CME and inducements 24

    DOJ settlement with device manufacturers 25

    Physician Sunshine Act may stifle innovation in the orthopedic device industry 27

    Impact of decline in hospital capital expenditure on orthopedics minimal in the near term 28

    Medical device industry bracing for the comparative effectiveness research (CER) era 29

    Medical device excise tax will influence orthopedic market top line 30

    Rising regulatory pressure on spinal device makers 30

    Chapter 3 Stryker 31

    Summary 31

    Company overview 31

    Marketed products 32

    Orthopedic implants 32

    MedSurg equipment 32

    Financial performance 32

    Orthopedic implants 34

    Hip implant systems 34

    Knee implant systems 34

    Trauma implant systems 34

    Spinal implant systems 35

    Craniomaxillofacial implant systems 35

    MedSurg equipments 35

    Surgical equipment and surgical navigation systems 35

    Endoscopic and communications systems 35

    Research and innovation 36

    Growth strategy 36

    SWOT 38

    Chapter 4 DePuy 39

    Summary 39

    Company overview 39

    Marketed products 40

    DePuy Orthopedics 40

    DePuy Spine 40

    DePuy Mitek 40

    Codman & Shurtleff 40

    Financial performance 41

    Research and product launches 42

    Growth strategy 42

    SWOT 44

    Chapter 5 Zimmer 45

    Summary 45

    Company overview 45

    Marketed products 45

    Reconstructive 45

    Dental 46

    Trauma 46

    Spine 46

    OSP 46

    Financial performance 46

    Reconstructive 48

    Knee 48

    Hip 48

    Extremities 49

    Dental 49

    Trauma 49

    Spine 49

    OSP 49

    Research and innovation 49

    Growth strategy 50

    SWOT 52

    Chapter 6 Medtronic 53

    Summary 53

    Company overview 53

    Marketed products 54

    Financial performance 54

    Core spinal 55

    Biologics 56

    Research and innovation 56

    Growth strategy 57

    SWOT 58

    Chapter 7 Synthes 59

    Summary 59

    Company overview 59

    Marketed products 59

    Trauma 59

    Spine 60

    CMF 60

    Financial performance 60

    Research and innovation 62

    Growth strategy 62

    SWOT 64

    Chapter 8 Smith & Nephew 65

    Summary 65

    Company overview 65

    Marketed products 66

    Orthopedics 66

    Endoscopy 66

    Financial performance 66

    Orthopedics 68

    Endoscopy 68

    Research and innovation 68

    Growth strategy 69

    SWOT 70

    Chapter 9 Biomet 71

    Summary 71

    Company overview 71

    Marketed products 71

    Reconstructive products 71

    Fixation devices 72

    Spinal products 72

    Other 72

    Financial performance 72

    Research and innovation 74

    Growth strategy 74

    SWOT 76

    Chapter 10 Orthofix 77

    Summary 77

    Company overview 77

    Marketed products 78

    Spinal products 78

    Orthopedic products 78

    Sports medicine 78

    Financial performance 78

    Spine 80

    Orthopedics 80

    Sports medicine 80

    Research and innovation 80

    Growth strategies 80

    SWOT 82

    Chapter 11 Wright Medical Group 83

    Summary 83

    Company overview 83

    Marketed products 83

    Hip products 83

    Knee products 83

    Extremity products 84

    Biologics products 84

    Financial performance 84

    Hip products 86

    Knee products 86

    Extremity products 86

    Biologic products 86

    Research and innovation 86

    Growth strategy 87

    SWOT 88

    Chapter 12 Conmed 89

    Summary 89

    Company overview 89

    Marketed products 89

    Arthroscopy 89

    Powered surgical instruments 90

    Financial performance 90

    Arthroscopy 92

    Powered surgical equipments 92

    Research and innovation 92

    Growth strategy 92

    SWOT 93

    Chapter 13 Other major companies 94

    NuVasive 94

    Integra LifeSciences 95

    Arthrocare 96

    Exactech 98

    RTI Biologics 99

    Appendix 101

    Abbreviations 101

    Table of figuresFigure 1: Orthopedic device global market performance, 2007–09 20

    Figure 2: Key drivers and resistors of the orthopedic market 24

    Figure 3: Effect of the Physician Payment Sunshine Act on the orthopedic market competitive

    landscape 28

    Figure 4: Stryker's financial performance, 2007–2009 33

    Figure 5: Stryker – SWOT 38

    Figure 6: DePuy's financial performance, 2007–2009 42

    Figure 7: DePuy – SWOT 44

    Figure 8: Zimmer's financial performance, 2007–2009 47

    Figure 9: Zimmer – SWOT 52

    Figure 10: Financial performance Medtronic's spinal business, 2007–2009 55

    Figure 11: Medtronic – SWOT 58

    Figure 12: Synthes' financial performance, 2007–2009 61

    Figure 13: Synthes – SWOT 64

    Figure 14: Smith & Nephew's financial performance, 2007–2009 67

    Figure 15: Smith & Nephew – SWOT 70

    Figure 16: Biomet's financial performance, 2007–2009 73

    Figure 17: Biomet – SWOT 76

    Figure 18: Financial performance of Orthofix's orthopedic operations, 2007–2009 79

    Figure 19: Orthofix – SWOT 82

    Figure 20: Wright Medical Group's financial performance, 2007–2009 85

    Figure 21: Wright Medical Group - SWOT 88

    Figure 22: Financial performance of Conmed's orthopedic operations, 2007–2009 91

    Figure 23: Conmed – SWOT 93

    Figure 24: NuVasive's financial performance, 2007–2009 95

    Figure 25: Financial performance of Integra LifeScience's orthopedic business, 2007–2009 96

    Figure 26: Financial performance of Arthrocare's orthopedic business, 2007–2009 98

    Figure 27: Exactech's financial performance, 2007–2009 99

    Figure 28: Financial performance of RTI Biologic's orthopedic business, 2007–2009 100

    Table of tablesTable 1: Orthopedic device global market performance, 2007–09 19

    Table 2: Global market sizes of orthopedic device segments, 2009 21

    Table 3: Market shares of top 15 orthopedic device companies, 2007–09 22

    Table 4: Orthopedic companies and surgeon/resident training programs 25

    Table 5: Settlements by orthopedic players to US DOJ 26

    Table 6: Stryker's financial performance, 2007–2009 32

    Table 7: Financial performance of Stryker's business units, 2008–2009 34

    Table 8: DePuy's financial performance, 2007–2009 41

    Table 9: Zimmer's financial performance, 2007–2009 47

    Table 10: Financial performance of Zimmer's business units, 2008–2009 48

    Table 11: Financial performance Medtronic's spinal business, 2007–2009 54

    Table 12: Financial performance of Medtronic's spinal business units, 2008–2009 55

    Table 13: Synthes' financial performance, 2007–2009 60

    Table 14: Smith & Nephew's financial performance, 2007–2009 66

    Table 15: Financial performance of Smith & Nephew's business units, 2008–2009 67

    Table 16: Biomet's financial performance, 2007–2009 73

    Table 17: Financial performance of Biomet's business units, 2008–09 74

    Table 18: Financial performance of Orthofix's orthopedic operations, 2007–2009 78

    Table 19: Performance of Orthofix's orthopedic product lines, 2008–2009 79

    Table 20: Wright Medical Group's financial performance, 2007–2009 84

    Table 21: Performance of Wright Medical Group's orthopedic product lines, 2008-2009 85

    Table 22: Financial performance of Conmed's orthopedic operations, 2007–2009 90

    Table 23: Performance of Conmed Linvatec's product lines, 2009 91

    Table 24: NuVasive's financial performance, 2007–2009 94

    Table 25: Financial performance of Integra LifeScience's orthopedic business, 2007–2009 96

    Table 26: Financial performance of Arthrocare's orthopedic business, 2007–2009 97

    Table 27: Exactech's financial performance, 2007–2009 99

    Table 28: Financial performance of RTI Biologic's orthopedic business, 2007–2009 100

    To order this report:  Orthopedic Industry: The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies

    Orthopedic Business News

    More  Market Research Report

    Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.com US: (805)652-2626Intl: +1 805-652-2626
    '/>"/>

    SOURCE Reportlinker
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Reportlinker Adds Cell Therapy - Technologies, Markets and Companies
    2. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
    3. Reportlinker Adds Global Dialysis Market -2013
    4. Reportlinker Adds Hypertension: Competing Treatments and Market Entry Considerations
    5. Reportlinker Adds US Pharmaceutical Packaging Market
    6. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
    7. Reportlinker Adds Global Life Sciences Tools and Services Market -2013
    8. Reportlinker Adds Gastroesophageal Reflux Disease Therapy Area Pipeline Report
    9. Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008
    10. Reportlinker Adds All Change in the Coronary Stent Market
    11. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... 2016 Research and Markets ... Electronics 2015-2025: Applications, Technologies, Forecasts" report to ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, Composite ... Structural electronics involves electronic and/or electrical components and ... dumb structures such as vehicle bodies or conformally ...
    (Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
    (Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
    Breaking Medicine Technology:
    (Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
    (Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
    (Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
    Breaking Medicine News(10 mins):